Headline News about Teva Pharmaceutical Industries ADR
Analyst Ratings for Teva Pharmaceutical Indus
January 19, 2023
Via Benzinga
Via Benzinga
4 Analysts Have This to Say About Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
November 10, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|